Anastasios Konidaris

Anastasios G.
Konidaris currently works at Zep, Inc., as Director from 2015, Kadmon Corp.
LLC, as Director from 2017, Amneal Intermediate, Inc., as Chief Financial Officer, and Amneal Pharmaceuticals, Inc., as Executive VP, Chief Financial & Accounting Officer from 2023.
Mr. Konidaris also formerly worked at Delcath Systems, Inc., as Independent Director from 2012 to 2014, Kadmon Holdings, Inc., as Independent Director from 2017 to 2019, Pernix Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2014 to 2017, Alcresta Therapeutics, Inc., as Chief Financial Officer, Director & Executive VP from 2016 to 2020, Schering-Plough Corp., as Group Vice President from 2003 to 2005, The Dun & Bradstreet Corp., as Chief Financial Officer & Senior Vice President from 2005 to 2011, Ikaria, Inc., as CFO, Executive VP & Head-Corporate Development from 2011 to 2015, and Pharmacia Corp., as Vice President-Finance-North America from 2000 to 2003.
Mr. Konidaris received his Masters Business Admin degree from Drexel University and undergraduate degree from Gwynedd-Mercy College.